These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 18575785

  • 1. Characteristics of GLP-1 and exendins action upon glucose transport and metabolism in type 2 diabetic rat skeletal muscle.
    Arnés L, González N, Tornero-Esteban P, Sancho V, Acitores A, Valverde I, Delgado E, Villanueva-Peñacarrillo ML.
    Int J Mol Med; 2008 Jul; 22(1):127-32. PubMed ID: 18575785
    [Abstract] [Full Text] [Related]

  • 2. Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states.
    Moreno P, Nuche-Berenguer B, Gutiérrez-Rojas I, Acitores A, Sancho V, Valverde I, González N, Villanueva-Peñacarrillo ML.
    J Mol Endocrinol; 2012 Feb; 48(1):37-47. PubMed ID: 22065862
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of exendin-4 treatment upon glucose uptake parameters in rat liver and muscle, in normal and type 2 diabetic state.
    Arnés L, Moreno P, Nuche-Berenguer B, Valverde I, Villanueva-Peñacarrillo ML.
    Regul Pept; 2009 Feb 25; 153(1-3):88-92. PubMed ID: 18804493
    [Abstract] [Full Text] [Related]

  • 5. Characteristic of GLP-1 effects on glucose metabolism in human skeletal muscle from obese patients.
    Villanueva-Peñacarrillo ML, Martín-Duce A, Ramos-Álvarez I, Gutiérrez-Rojas I, Moreno P, Nuche-Berenguer B, Acitores A, Sancho V, Valverde I, González N.
    Regul Pept; 2011 Jun 07; 168(1-3):39-44. PubMed ID: 21419173
    [Abstract] [Full Text] [Related]

  • 6. Participation of protein kinases in the stimulant action of GLP-1 on 2-deoxy-D-glucose uptake by normal rat skeletal muscle.
    Acitores A, González N, Sancho V, Arnés L, Valverde I, Malaisse WJ, Villanueva-Peñacarrillo ML.
    Horm Metab Res; 2005 May 07; 37(5):275-80. PubMed ID: 15971149
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The action of GLP-1 and exendins upon glucose transport in normal human adipocytes, and on kinase activity as compared to morbidly obese patients.
    Sancho V, Nuche B, Arnés L, Cancelas J, González N, Díaz-Miguel M, Martín-Duce A, Valverde I, Villanueva-Peñacarrillo ML.
    Int J Mol Med; 2007 Jun 07; 19(6):961-6. PubMed ID: 17487430
    [Abstract] [Full Text] [Related]

  • 9. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
    Vella A, Shah P, Reed AS, Adkins AS, Basu R, Rizza RA.
    Diabetologia; 2002 Oct 07; 45(10):1410-5. PubMed ID: 12378382
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
    Márquez L, González N, Puente J, Valverde L, Villanueva-Peñacarrillo ML.
    Diabetes Nutr Metab; 2001 Oct 07; 14(5):239-44. PubMed ID: 11806463
    [Abstract] [Full Text] [Related]

  • 12. Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle.
    Acitores A, González N, Sancho V, Valverde I, Villanueva-Peñacarrillo ML.
    J Endocrinol; 2004 Mar 07; 180(3):389-98. PubMed ID: 15012593
    [Abstract] [Full Text] [Related]

  • 13. GLP-1 (7-36) amide: effects on glucose transport and metabolism in rat adipose tissue.
    Perea A, Viñambres C, Clemente F, Villanueva-Peñacarrillo ML, Valverde I.
    Horm Metab Res; 1997 Sep 07; 29(9):417-21. PubMed ID: 9370107
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.
    Ozyazgan S, Kutluata N, Afşar S, Ozdaş SB, Akkan AG.
    Pharmacology; 2005 Jun 07; 74(3):119-26. PubMed ID: 15746570
    [Abstract] [Full Text] [Related]

  • 16. Exendin-4 agonist and exendin(9-39)amide antagonist of the GLP-1(7-36)amide effects in liver and muscle.
    Alcántara AI, Morales M, Delgado E, López-Delgado MI, Clemente F, Luque MA, Malaisse WJ, Valverde I, Villanueva-Peñacarrillo ML.
    Arch Biochem Biophys; 1997 May 01; 341(1):1-7. PubMed ID: 9143346
    [Abstract] [Full Text] [Related]

  • 17. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.
    Henriksen EJ, Kinnick TR, Teachey MK, O'Keefe MP, Ring D, Johnson KW, Harrison SD.
    Am J Physiol Endocrinol Metab; 2003 May 01; 284(5):E892-900. PubMed ID: 12517738
    [Abstract] [Full Text] [Related]

  • 18. GLP-1 signalling and effects on glucose metabolism in myocytes from type 2 diabetic patients.
    González N, Sancho V, Martín-Duce A, Tornero-Esteban P, Valverde I, Malaisse WJ, Villanueva-Peñacarrillo ML.
    Int J Mol Med; 2005 Oct 01; 16(4):747-52. PubMed ID: 16142415
    [Abstract] [Full Text] [Related]

  • 19. Biological activity of AC3174, a peptide analog of exendin-4.
    Hargrove DM, Kendall ES, Reynolds JM, Lwin AN, Herich JP, Smith PA, Gedulin BR, Flanagan SD, Jodka CM, Hoyt JA, McCowen KM, Parkes DG, Anderson CM.
    Regul Pept; 2007 Jun 07; 141(1-3):113-9. PubMed ID: 17292977
    [Abstract] [Full Text] [Related]

  • 20. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
    Kim JY, Lee SK, Jo KJ, Song DY, Lim DM, Park KY, Bonewald LF, Kim BJ.
    Life Sci; 2013 Mar 21; 92(10):533-40. PubMed ID: 23357248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.